In a Turkish study, injection-related anxiety, fear of diabetes deterioration, the difficulty of dosing accuracy, dependence on others, social stigma, and reduced quality of life were the most common barriers, resulting in the patient’s resistance to initiate insulin [20]. The gene discussed is INS; the disease is diabetes mellitus.